Joint animal research by OHSU, George Washington University and Mabloc, LLC, suggests monoclonal antibody infusions offer a potential cure for serious cases of yellow fever.

KGW-TV profiles a study led by Kerri Winters-Stone, Ph.D., that uses exercise to improve the health of both cancer patients and their partners. Winters-Stone says: “If the patient gets healthier, the spouse gets healthier, and then their relationship gets stronger and that really maximizes the long-term health for that couple."

A talk by Sancy Leachman, M.D., Ph.D., on the need for the early detection of melanoma was included in the American Journal of Managed Care's list of the top 5 stories from the American Academy of Dermatology annual meeting.

In an American Medical Association article on the difficulties in transitioning to practice for radiation oncologists, Jenna Kahn, M.D., says: "Due to the complexity and disease-site-specific nature of the field, radiation oncology residency training has traditionally adopted an apprentice-style format, which affords limited opportunity for independent practice prior to graduation."

While describing how a 16-year-old girl was able to see snowflakes for the first time after participating in a clinical trial for a gene therapy designed to treat a rare form of inherited blindness, Paul Yang, M.D., Ph.D., says “As a physician-scientist who works to develop and bring new treatments to patients, it’s an honor to be among the first who get to witness signs of clinical success like this.”

While describing how a 16-year-old girl was able to see snowflakes for the first time after participating in a clinical trial for a gene therapy designed to treat a rare form of inherited blindness, Paul Yang, M.D., Ph.D., says “As a physician-scientist who works to develop and bring new treatments to patients, it’s an honor to be among the first who get to witness signs of clinical success like this.”

Flavio Rocha, M.D., is named chair of the Cancer Surgery Standards Program (CSSP) Standards Development Committee.

This article highlights House Bill 2002, a bill intended to guarantee access to abortion and gender-affirming care. Christina Milano, M.D., said during a hearing last month that coverage would already include people who seek to transition back to their original gender.

Mark Pennesi, M.D., Ph.D., is the lead investigator for a Phase 1/2 clinical trial investigating the safety and tolerability of an experimental treatment for retinitis pigmentosa, which causes vision loss.

In a video interview with OncLive, Alexandra Sokolova, M.D., discusses remaining questions and next steps with PARP inhibitors in the prostate cancer treatment paradigm.